As of November 6, 2026, Grace Therapeutics, Inc. is a publicly traded company (Nasdaq: GRCE); its largest reported holder is Opaleye Management Inc., with 13.07% on Schedule 13G of August 7, 2026, then ADAR1 Capital (9.9%) (Schedule 13G, August 7, 2026).
Is this your company?
About to sign with, pay or invest in Grace Therapeutics, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Grace Therapeutics, Inc. a real, registered company?
- Grace Therapeutics, Inc. files with the SEC under CIK 1444192 (its SEC filings).
- Its shares are listed under the ticker GRCE on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Princeton, New Jersey, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Grace Therapeutics, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Nantahala Capital (filed 2026-08-14).
Who are Grace Therapeutics, Inc.'s owners and officers?
Grace Therapeutics, Inc.: incorporated in Delaware; business address in Princeton, New Jersey; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-08-14).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2026-08-11)
- : Director (Form D, 2026-08-11)
- : Executive Officer (Form D, 2026-08-11)
- : Director (Form D, 2026-08-11)
- : Director (Form D, 2026-08-11)
- : Director (Form D, 2026-08-11)
- : Executive Officer (Form D, 2026-08-11)
- : Executive Officer (Form D, 2026-08-11)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Nantahala Capital Management, LLC | 6.75% |
| Schedule 13G/A, 2026-08-14 | Adar1 Capital Management, LLC | 9.9% |
| Schedule 13G, 2026-08-07 | Opaleye Management Inc. | 13.07% |
| Schedule 13G/A, 2026-05-15 | Adar1 Capital Management, LLC | 9.9% |
| Schedule 13G/A, 2026-04-27 | Orin Hirschman | 4.9% |
| Schedule 13G/A, 2026-02-17 | Adar1 Capital Management, LLC | 9.9% |
| Schedule 13G/A, 2026-02-13 | Nantahala Capital Management, LLC | 9.99% |
| Schedule 13G/A, 2026-01-28 | Orin Hirschman | 5.9% |
| Schedule 13G/A, 2025-11-14 | Adar1 Capital Management, LLC | 9.9% |
| Schedule 13G/A, 2025-08-14 | Nantahala Capital Management, LLC | 9.99% |
Questions about who owns Grace Therapeutics, Inc.
Who owns Grace Therapeutics, Inc.?
On this page, 3 holders' latest ownership filings report 5% or more of Grace Therapeutics, Inc.: Opaleye Management Inc. (13.07%, Schedule 13G, filed 2026-08-07), Adar1 Capital Management, LLC (9.9%, Schedule 13G/A, filed 2026-08-14) and Nantahala Capital Management, LLC (6.75%, Schedule 13G/A, filed 2026-08-14).
Who are the largest shareholders of Grace Therapeutics, Inc.?
By the share each holder's latest filing reports, the largest holders of Grace Therapeutics, Inc. on this page are Opaleye Management Inc. (13.07%), Adar1 Capital Management, LLC (9.9%) and Nantahala Capital Management, LLC (6.75%).
When did Opaleye Management Inc. buy into Grace Therapeutics, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Opaleye Management Inc. on this page is the Schedule 13G, filed 2026-08-07, reporting 13.07%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 10 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Grace Therapeutics, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Grace Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Grace Therapeutics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
16 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Grace Therapeutics, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- Opaleye Management Inc., a 10% owner: 3,054,853 shares (14.5% of shares outstanding), held indirectly through By Opaleye, L.P. (Form 4, 2026-11-05).
- , the chief executive and a director: 121,357 shares (0.58% of shares outstanding) (Form 4, 2026-09-10).
Shares outstanding: 21,035,930 as of 2026-08-11, from the company's latest SEC cover page.
How much has Grace Therapeutics, Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2026-08-11 | $10M | $10M |
| Form D, 2025-02-25 | $15M | $30M |
| Form D, 2023-10-10 | $7.50M | $15.12M |
Keep reading
More on Grace Therapeutics, Inc. and the records around it.
Grace Therapeutics, Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
- Company profile and every filing Aug 2026
- Form D filing Aug 2026
Companies that share a holder
- Opaleye Management Inc. also filed stake reports on 12 other companies: Codexis, Inc. (Nov 2026), Gossamer Bio, Inc. (Nov 2026), Pasithea Therapeutics Corp. (Nov 2026)
- ADAR1 Capital Management, LLC also filed stake reports on 29 other companies: InMed Pharmaceuticals, Inc. (Oct 2026), Tenax Therapeutics, Inc. (Sep 2026), Adagio Medical Holdings, Inc. (Aug 2026)
- Orin Hirschman also filed stake reports on 46 other companies: ASPEN AEROGELS, INC. (Oct 2026), Bionano Genomics, Inc. (Oct 2026), FENNEC PHARMACEUTICALS INC. (Oct 2026)
Related pages
Funding and filing history5%+ holders
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/grace-therapeutics-inc